Drug class in one race
Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs for Atherosclerotic Cardiovascular Disease
2 tracked Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the Angiotensin II receptor / Calcium channel / HMG-CoA reductase page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
2 Phase 3
Head-to-head evidence: CJ-30061 vs OLOMAX
The roster
← all Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs